# Trial to Assess the Efficacy of EMPAgliflozin and Personalized Dietary Counseling for Kidney STONE Prevention

> **NCT06653738** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 380 (estimated)

## Conditions studied

- Kidney Stone
- Nephrolithiasis
- Dietary Exposure

## Interventions

- **DRUG:** Empagliflozin 25 MG
- **DRUG:** Placebo
- **BEHAVIORAL:** Personalized dietary counseling
- **BEHAVIORAL:** Generic dietary counseling

## Key facts

- **NCT ID:** NCT06653738
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05
- **Primary completion:** 2030-02
- **Final completion:** 2030-06
- **Target enrollment:** 380 (ESTIMATED)
- **Last updated:** 2024-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06653738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06653738, "Trial to Assess the Efficacy of EMPAgliflozin and Personalized Dietary Counseling for Kidney STONE Prevention". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06653738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*